{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:32:43Z","timestamp":1773869563564,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Percutaneous left atrial appendage (LAA) occlusion is effective for stroke prevention in patients with atrial fibrillation. LAA can have a complex anatomy, such as multiple lobes or a large orifice, which may render it unsuitable for occlusion using regular devices. We aimed to investigate the feasibility, safety, and short-term efficacy of the small-umbrella LAmbre device for morphologically complicated LAA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively enrolled 129 consecutive patients who underwent LAA occlusion using the LAmbre device; the small-umbrella LAmbre device was used in 30 of these patients. We analyzed patients\u2019 characteristics, procedural details, and outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-two patients (73.3%) had multilobed (\u2265\u20092) LAA. The umbrella of the occluder was anchored in the branch in 9 patients and in the common trunks of branches in 13 patients. The landing zone and orifice diameters were 19.0\u2009\u00b1\u20094.39\u00a0mm and 27.4\u2009\u00b1\u20093.95\u00a0mm, respectively. The sizes of the umbrella and occluder cover were 22.0\u2009\u00b1\u20093.42\u00a0mm and 34.3\u2009\u00b1\u20092.75\u00a0mm, respectively. At 3-month follow-up transesophageal echocardiography in 24 patients, no peri-device residual flow was reported. Device thrombosis was detected in one patient at 3\u00a0months and disappeared after 3\u00a0months of anticoagulation. Ischemic stroke occurred in one patient; no other adverse events were reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Occlusion of morphologically complicated LAA using the small-umbrella LAmbre device was feasible, safe, and effective in patients with atrial fibrillation in this study. This occluder provides an alternative for patients who cannot be treated with regular-sized LAA occlusion devices.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-022-02770-y","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T03:33:49Z","timestamp":1658547229000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Occluding morphologically complicated left atrial appendage using the small-umbrella LAmbre device"],"prefix":"10.1186","volume":"22","author":[{"given":"Hong-Da","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Bo","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Xian","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Tong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Xing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Jie","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Yuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pi-Hua","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"2770_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42:373\u2013498.","journal-title":"Eur Heart J"},{"key":"2770_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW. AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74:104\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"2770_CR3","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1136\/bmj.2.4946.1000","volume":"2","author":"JR Belcher","year":"1955","unstructured":"Belcher JR, Somerville W. Systemic embolism and left auricular thrombosis in relation to mitral valvotomy. BMJ. 1955;2:1000\u20133.","journal-title":"BMJ"},{"key":"2770_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/00000441-194103000-00014","volume":"201","author":"C Garvin","year":"1941","unstructured":"Garvin C. Mural thrombi in the heart as a source of emboli. Am J Med Sci. 1941;201:412\u20135.","journal-title":"Am J Med Sci"},{"key":"2770_CR5","first-page":"344","volume":"24","author":"IR Graef","year":"1937","unstructured":"Graef IR, Berger AR, Bunim JJ, De La Chapelle CE. Auricular thrombosis in rheumatic heart disease. Arch Path. 1937;24:344.","journal-title":"Arch Path"},{"key":"2770_CR6","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/archinte.1987.00370090041008","volume":"147","author":"PA Wolf","year":"1987","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Internal Med. 1987;147:1561\u20134.","journal-title":"Arch Internal Med"},{"key":"2770_CR7","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJM198204293061703","volume":"306","author":"WB Kannel","year":"1982","unstructured":"Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982;306:1018\u201322.","journal-title":"N Engl J Med"},{"key":"2770_CR8","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1212\/WNL.28.10.973","volume":"28","author":"PA Wolf","year":"1978","unstructured":"Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978;28:973\u20137.","journal-title":"Neurology"},{"key":"2770_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","volume":"61","author":"JL Blackshear","year":"1996","unstructured":"Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755\u20139.","journal-title":"Ann Thorac Surg"},{"key":"2770_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/europace\/euz258","volume":"22","author":"M Glikson","year":"2019","unstructured":"Glikson M, Wolff R, Hindricks G, Mandrola J, Camm AJ, Lip GYH, Fauchier L, Betts TR, Lewalter T, Saw J, Tzikas A, Sternik L, Nietlispach F, Berti S, Sievert H, Bertog S, Meier B, Group ESCSD. EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion\u2014an update. EP Europace. 2019;22:184.","journal-title":"EP Europace"},{"key":"2770_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10840-020-00752-8","volume":"61","author":"E Tay","year":"2020","unstructured":"Tay E, Paul B, Sharp J, Wang D, Chui ASF, Hazra PK, Santoso T, Albers B, Diener HC, Lewalter T, Wong A. Left atrial appendage occlusion for ischemic stroke prevention in patients with non-valvular atrial fibrillation: clinical expert opinion and consensus statement for the Asian-Pacific region. J Interv Card Electrophysiol. 2020;61:269\u201381.","journal-title":"J Interv Card Electrophysiol"},{"key":"2770_CR12","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1001\/jama.2014.15192","volume":"312","author":"VY Reddy","year":"2014","unstructured":"Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P, Huber K, Whisenant B, Kar S, Swarup V, Gordon N, Holmes D. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014;312:1988\u201398.","journal-title":"JAMA"},{"key":"2770_CR13","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet (London, England). 2009;374:534\u201342.","journal-title":"Lancet (London, England)"},{"key":"2770_CR14","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1161\/01.CIR.0000015605.30810.51","volume":"105","author":"T Nakai","year":"2002","unstructured":"Nakai T, Lesh MD, Gerstenfeld EP, Virmani R, Jones R, Lee RJ. Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine model. Circulation. 2002;105:2217\u201322.","journal-title":"Circulation"},{"key":"2770_CR15","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.jcin.2017.06.072","volume":"10","author":"H Huang","year":"2017","unstructured":"Huang H, Liu Y, Xu Y, Wang Z, Li Y, Cao K, Zhang S, Yang Y, Yang X, Huang D, Yu B, Su X, Wu L, Huang C. Percutaneous left atrial appendage closure with the LAmbre device for stroke prevention in atrial fibrillation: a prospective. Multicenter Clinical Study JACC Cardiovasc Interv. 2017;10:2188\u201394.","journal-title":"Multicenter Clinical Study JACC Cardiovasc Interv"},{"key":"2770_CR16","first-page":"4","volume":"19","author":"A Tzikas","year":"2017","unstructured":"Tzikas A, Holmes DR Jr, Gafoor S, Ruiz CE, Blomstrom-Lundqvist C, Diener HC, Cappato R, Kar S, Lee RJ, Byrne RA, Ibrahim R, Lakkireddy D, Soliman OI, Nabauer M, Schneider S, Brachmann J, Saver JL, Tiemann K, Sievert H, Camm AJ, Lewalter T. Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies. EP Europace. 2017;19:4\u201315.","journal-title":"EP Europace"},{"key":"2770_CR17","first-page":"5359","volume":"10","author":"L Asmarats","year":"2017","unstructured":"Asmarats L, Rodes-Cabau J. Percutaneous left atrial appendage closure: current devices and clinical outcomes. Circul Cardiovasc Interv. 2017;10:5359.","journal-title":"Circul Cardiovasc Interv"},{"key":"2770_CR18","first-page":"6613683","volume":"2020","author":"G Wang","year":"2020","unstructured":"Wang G, Kong B, Liu Y, Huang H. Long-term safety and efficacy of percutaneous left atrial appendage closure with the LAmbre device. J Interv Cardiol. 2020;2020:6613683.","journal-title":"J Interv Cardiol"},{"key":"2770_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/jce.13385","volume":"29","author":"S Chen","year":"2018","unstructured":"Chen S, Schmidt B, Bordignon S, Bologna F, Nagase T, Tsianakas N, Perrotta L, Chun KRJ. Feasibility of percutaneous left atrial appendage closure using a novel LAmbre occluder in patients with atrial fibrillation: initial results from a prospective cohort registry study. J Cardiovasc Electrophysiol. 2018;29:291\u20137.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2770_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ijcard.2018.02.120","volume":"265","author":"JW Park","year":"2018","unstructured":"Park JW, Sievert H, Kleinecke C, Vaskelyte L, Schnupp S, Sievert K, Lam YY, St\u00e4hli BE, Zhang D, Li A, Brachmann J. Left atrial appendage occlusion with Lambre in atrial fibrillation: initial European experience. Int J Cardiol. 2018;265:97\u2013102.","journal-title":"Int J Cardiol"},{"key":"2770_CR21","first-page":"E41","volume":"31","author":"CY So","year":"2019","unstructured":"So CY, Lam YY, Cheung GS, Kam KK, Chan AK, Lee AP, Yan BP. Occlusion of a multilobed shallow left atrial appendage using a special LAmbre device after failed watchman implantation. J Invasive Cardiol. 2019;31:E41-e42.","journal-title":"J Invasive Cardiol"},{"key":"2770_CR22","doi-asserted-by":"publisher","first-page":"968.e15","DOI":"10.1016\/j.cjca.2020.01.021","volume":"36","author":"I Cruz-Gonz\u00e1lez","year":"2020","unstructured":"Cruz-Gonz\u00e1lez I, Trejo-Velasco B, Barreiro-P\u00e9rez M, N\u00fa\u00f1ez JC, Gonz\u00e1lez-Ferreiro R, Rodr\u00edguez-Collado J, S\u00e1nchez PL. Large left-atrial appendage occlusion with 2 simultaneous LAmbre devices: the more, the better? Can J Cardiol. 2020;36:968.e15-968.e16.","journal-title":"Can J Cardiol"},{"key":"2770_CR23","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/jce.14398","volume":"31","author":"S Schnupp","year":"2020","unstructured":"Schnupp S, Liu XX, Buffle E, Gloekler S, Mohrez Y, Cheikh-Ibrahim M, Allakkis W, Brachmann J, Park JW, Kleinecke C. Late clinical outcomes of lambre versus amplatzer occluders for left atrial appendage closure. J Cardiovasc Electrophysiol. 2020;31:934\u201342.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2770_CR24","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1161\/01.CIR.96.9.3112","volume":"96","author":"JP Veinot","year":"1997","unstructured":"Veinot JP, Harrity PJ, Gentile F, Khandheria BK, Bailey KR, Eickholt JT, Seward JB, Tajik AJ, Edwards WD. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Circulation. 1997;96:3112\u20135.","journal-title":"Circulation"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02770-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02770-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02770-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T03:34:34Z","timestamp":1658547274000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02770-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2770"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02770-y","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,23]]},"assertion":[{"value":"31 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and was approved by Ethics Committee of Fuwai Hospital (Approval Number: 2021-1575) on 06 December 2021. Informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"326"}}